Division of Plastic Surgery, Baylor College of Medicine, Houston, Texas.
Semin Plast Surg. 2007 Aug;21(3):159-66. doi: 10.1055/s-2007-991184.
Since its introduction in 1967, laser therapy has benefited patients and physicians alike. After the first clinical application by Goldman (Anderson RR, Parrish JA. Science 1983;220:524-527), laser therapy has become indispensable in the management of vascular birthmarks. In selecting a proper balance of wavelength, pulse duration, and energy density (fluence), the physician can mold laser energy to effectively manage lesions once considered untreatable. Now, the vast array of lesions amenable to laser therapy continues to expand. By advancing our understanding of both laser technology and vascular lesion biology, the goal of providing optimal clearance with minimal morbidity moves ever closer.
自 1967 年问世以来，激光疗法使患者和医生均受益。在 Goldman 进行首次临床应用（Anderson RR，Parrish JA. Science 1983;220:524-527）后，激光疗法已成为血管性胎记治疗不可或缺的手段。医生在选择适当的波长、脉冲持续时间和能量密度（通量）平衡时，可以将激光能量塑形，从而有效治疗以前被认为无法治疗的病变。如今，能够接受激光治疗的病变种类繁多且不断增加。通过提高对激光技术和血管性病变生物学的认识，以最小的发病率实现最佳清除率的目标越来越近。
